What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Cirrhosis
Internal medicine, Cirrhosis, Portal hypertension, Portal venous pressure and Surgery are his primary areas of study.
His Internal medicine research integrates issues from Gastroenterology, Endocrinology and Cardiology.
His research investigates the link between Gastroenterology and topics such as Hepatitis C that cross with problems in Decompensation.
Jaume Bosch combines subjects such as Liver disease, Randomized controlled trial, Pathology and Liver transplantation with his study of Cirrhosis.
His study in Portal venous pressure is interdisciplinary in nature, drawing from both Esophageal varices, Varices, Blood pressure and Propranolol.
His Surgery research incorporates themes from Radiology and Transjugular intrahepatic portosystemic shunt.
His most cited work include:
- Angiogenesis in liver disease (423 citations)
- Improved Clinical Outcome Using Polytetrafluoroethylene-Coated Stents for TIPS: Results of a Randomized Study (380 citations)
- Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation (358 citations)
What are the main themes of his work throughout his whole career to date?
Jaume Bosch mostly deals with Internal medicine, Portal hypertension, Cirrhosis, Portal venous pressure and Endocrinology.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Cardiology.
His work carried out in the field of Portal hypertension brings together such families of science as Radiology, Liver function, Varices and Surgery.
His Cirrhosis study combines topics in areas such as Liver disease, Hepatitis C, Randomized controlled trial and Ascites.
His Portal venous pressure study combines topics from a wide range of disciplines, such as Decompensation, Anesthesia, Propranolol, Blood pressure and Esophageal varices.
His Hemodynamics research includes elements of Blood volume and Somatostatin.
He most often published in these fields:
- Internal medicine (83.65%)
- Portal hypertension (60.38%)
- Cirrhosis (59.12%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (83.65%)
- Cirrhosis (59.12%)
- Portal hypertension (60.38%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Cirrhosis, Portal hypertension, Portal venous pressure and Gastroenterology.
His study in the fields of Portopulmonary hypertension, Vascular resistance and Clinical trial under the domain of Internal medicine overlaps with other disciplines such as Macitentan and Population.
His studies in Portal hypertension integrate themes in fields like Liver function, Ascites and Intensive care medicine.
His research in Portal venous pressure intersects with topics in Decompensation, Cardiology and Surgery.
Jaume Bosch focuses mostly in the field of Surgery, narrowing it down to topics relating to Esophageal varices and, in certain cases, Liver disease.
His research integrates issues of Portal vein, Prospective cohort study, Venous thrombosis and Beta in his study of Gastroenterology.
Between 2016 and 2021, his most popular works were:
- Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis. (133 citations)
- Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis. (133 citations)
- Impaired endothelial autophagy promotes liver fibrosis by aggravating the oxidative stress response during acute liver injury (49 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Pathology
His main research concerns Portal venous pressure, Portal hypertension, Internal medicine, Liver disease and Hepatic stellate cell.
His Portal venous pressure study contributes to a more complete understanding of Cirrhosis.
His specific area of interest is Portal hypertension, where Jaume Bosch studies Transjugular intrahepatic portosystemic shunt.
His work on Portopulmonary hypertension, Vascular resistance and Clinical endpoint as part of general Internal medicine research is frequently linked to Macitentan and Placebo, bridging the gap between disciplines.
His Liver disease research is multidisciplinary, incorporating elements of Fibrosis and Liver cell.
He has researched Surgery in several fields, including Gastroenterology, Esophageal varices, Hepatitis C and Decompensation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
